In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

Popular Nigerian music video director ThankGod Smith Omori, popularly known as TG Omori, has spoken about his ongoing ...

Clinical trial evaluating changes in urine protein-to-creatinine ratio, a widely-accepted endpoint measuring risk reduction ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...